We’re now well over half a year into the Covid-19 pandemic, and the lack of a vaccine is excruciating. With dozens of candidate vaccines generating countless headlines about positive results in early stage trials, it’s tempting to see any further delay as unnecessary. If we know that these vaccines work, can’t we follow China’s lead by picking one and starting mass distribution?

If only things were so simple. The sad truth is that large-scale trials are more than a needless formality. …

Max Rosett

Data scientist and data skeptic. Director of Data Science at Research Bridge Partners. Aspiring mountain man.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store